Luminex Verigene Respiratory Pathogens Test Recalled for False-Negative Risk
Luminex Corporation is recalling 38,990 Verigene Respiratory Pathogens Flex nucleic acid tests due to potential false-negative results. The tests were distributed worldwide, including throughout the United States.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or confirmed false-negative incidents. The potential for false-negative results in a diagnostic test poses theoretical clinical risk of missed diagnoses, which does not meet the Severe threshold due to absence of reported actual harm.
Plain-English summary
Luminex Corporation is recalling the Verigene Respiratory Pathogens Flex Nucleic Acid Test (Model Number 20-006-024) due to a potential for false-negative results in test outcomes.
A false-negative result could prevent the detection of respiratory pathogens in patient samples, potentially delaying or missing diagnosis of respiratory infections. This issue affects the reliability of test results in clinical settings.
Approximately 38,990 units were distributed worldwide, including to healthcare facilities throughout the United States (all 50 states plus DC) and internationally to Austria, Chile, France, Germany, Greece, Italy, Japan, Kuwait, Netherlands, Spain, Thailand, Turkey, and the United Kingdom. Affected lot codes include 030520024A, 030720024A, 031020024A, 031120024A, 031320024A, 031620024C, 031820024A, and numerous others through 091120024A.
Healthcare providers currently using these tests should review the FDA recall notification and contact Luminex Corporation for guidance. Patients who may have received a negative result from one of these tests should consult with their healthcare provider about potential follow-up testing.
The recalled product
- Product
- Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) Model Number: 20-006-024
- Manufacturer
- Luminex Corporation
- Category
- Medical Device — Diagnostic Test
- Affected units
- 38,990
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- 030520024A
- 030720024A
- 031020024A
- 031120024A
- 031320024A
- 031620024C
- 031820024A
- 031920024A
- 032120024A
- 032320024A
- 032420024A
- 032620024A
- 033120024A
- 040220024A
- 040320024A
- 040420024A
- 040620024A
- 040720024A
- 040920024A
- 041120024A
Distribution
Part of a larger recall action
This product is one of 6 recalled by Luminex Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Luminex Corporation
See all →- HighLuminex VERIGENE Gram Negative Blood Culture Test Recalled
FDA (Devices) · 2025-06-11
- HighVerigene Gram Positive Blood Culture Test Recalled for Defective Cartridges
FDA (Devices) · 2024-08-14
- ModerateLuminex VERIGENE BC-GP Utility Trays Recalled Due to Potential Defects
FDA (Devices) · 2023-12-13
- HighVerigene nucleic acid test kits recalled for rare false-negative results
FDA (Devices) · 2023-07-05
- HighVERIGENE Clostridium difficile Nucleic Acid Test May Give False-Negative Results
FDA (Devices) · 2023-07-05
Same hazard · false negative result
See all →- HighBioFire Respiratory Panel 2.1 Recalled for Increased False Negative Results
FDA (Devices) · 2026-08-19
- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighMedical device test system recalled for decreased reactivity and false-negative results
FDA (Devices) · 2022-12-07
- HighARIES SARS-CoV-2 Assay Recalled Due to Syringe Defect
FDA (Devices) · 2022-11-02
- HighLaboratory device displays incorrect sample volume guidance during setup
FDA (Devices) · 2022-09-21